Home > AGRiMED Leadership Team Paving the Way for Medical Cannabis in PA

Bookmark and Share

AGRiMed Leadership Team Paving the Way for Medical Cannabis in PA

PUM  catches up with some of the top Innovators at this company who are focused on advancing health for people who can benefit from medicines derived from cannabinoid compounds while also creating jobs in the state.


The Pennsylvania Department of Health released information on the issuance of 12 permits for medical marijuana growers/processors in the state on June 20, 2017.  

The Medical Marijuana Program was signed into law by Governor Tom Wolf on April 17, 2016, under this new program, AGRiMED Industries of Pa. LLC was granted one of 12 permits by the state Department of Health to grow and process medical marijuana under the state’s new medical marijuana program, and the Philadelphia company, which plans to invest $25 million to develop its growing operation near Nemacolin, now has six months to get the project up and running.


Statements from AGRiMED Regarding Being Granted one of the 12 permits:

“We are honored to have been selected by the Commonwealth of Pennsylvania to be one of the first medical cannabis cultivators given the opportunity to begin the process of relief to the pain and suffering of the citizens of Pennsylvania. The selection of AGRiMED today provides us with the opportunity to achieve some of our own company’s core values. One of these goals is empowering underserved and underrepresented communities. AGRiMED is so pleased to be able to bring real economic opportunities back to Greene County, which is one county among many that have been hit hard by the economic downturn over the last few decades.”

The statement continues, “Another of AGRiMED’s goals is improving the quality of life for as many people as possible. This drives AGRiMED’s desire to harness the natural power of the cannabis plant to create nature-based medicines capable of relieving a growing list of ailments. Improving the quality of life is also why AGRiMED will work with and educate local community caregivers to provide our cannabis-infused medicines to patients in need of alternatives to pain management in the face of the opioid epidemic.” 

AGRiMED, a highly specialized medical cannabis cultivation company, will grow its inaugural crop in a new state-of-the-art facility that will help serve patients with medicines derived from cannabinoid compounds.

"The core of our model is the cultivation and processing of medical grade cannabis plants into pharmaceutical medicines that can improve health and wellness to patients in need," said Bruce Goldman, CEO of AGRiMED. "Through employing world-class professionals in agriculture and technology, we are able to carry out our mission to be a market leader that is rooted in science and centered on superior patient care."

With a plan to spur economic growth from the time we plant our first seeds, AGRiMED will invest $25 million to cultivate and develop 61 acres in Greene County.

"Spending time meeting with patients, government officials, business leaders, community leaders and law enforcement - one thing can be said: the support has been phenomenal and they understand what this medicine can do for the community," said Sterling Crockett, Managing Partner of AGRiMED Industries.

"We intend to leverage local sources of energy to create a healthier economic environment for Greene County and leave a smaller carbon footprint on our surrounding community."





 Bruce Goldman-Chairman of the Board

PUM: Tell us more about the process of being selected, was  it a very competitive process? What did your organization offer that made you a viable corporation?

Goldman: We created a healthcare company that's focused on creating medical cannabis products and brought experienced healthcare experts to develop AGRiMED. 

PUM: Your company will be one of only two state-sanctioned medical cannabis farms in the Southwest region, what is the scope of this project and the responsibility associated with this opportunity?

Goldman: AGRiMED is building a greenhouse facility with the most modern technology that will allow for service for the entire Commonwealth. The primary responsibility is to consistently produce safe products for patients.

PUM: Your firm's leadership team is very qualified executives, many who are African American? What about the wealth of knowledge you have in your company.

Goldman: That experience is what we felt gave us the ability to compete.

PUM: In the very competitive business of gaining work in the field of securing Medical Cannabis Permits for Dispensaries will we see more African Americans get in the game?

Goldman: Of course. We have to continue to believe in ourselves, network with others, research, plan, execute.

PUM: Tell us more about your core values at AGRiMed, it is reported that one of your goals is empowering undeserved and underrepresented communities.

Goldman: We believe that our company must do more than create quality employment. AGRiMED must also create entrepreneurs. That is even more important. We must use the industries to create job creators.

PUM:  Another one of your goals outlined is to improve the quality of life for as many people as possible.  You believe this will be accomplished by harnessing the natural power of the cannabis plant to create nature-based medicines capable of relieving a growing list of ailments.

Goldman: AGRiMED intends to be a leader in the research of cannabis and hemp. This new information and discovery will change lives for the better all over the world.


Dr. Eric Mitchell, MD, FACPE


PUM: Why is this venture important to each of you respectively?

Dr. Mitchell: I think that it is an incredible opportunity to be able to be on the ground floor of an emerging industry and have a big impact upon it. 

 PUM:  Another one of your goals outlined is to improve the quality of life for as many people as possible.  You believe this will be accomplished by harnessing the natural power of the cannabis plant to create nature-based medicines capable of relieving a growing list of ailments.

Dr. Mitchell: The power of the cannabis plant has been coveted for the last forty-seven years by a Presidential Executive Order which took this plant-based medicine and put it into a classification under the Controlled Substance Act denoting it as a Schedule I drug. 

Schedule I drugs under the Controlled Substance Act (CSA) are classified as deadly, dangerous, highly addictive and stated to have no medical efficacy.  These facts are incorrect when we look at the total history of cannabis which goes back thousands of years and paints a different picture.  From a broad paintbrush perspective, cannabis existed in our pharmacopeia for almost 100 years before it was politically banned. 

It was California Proposition 215 in 1996 that gave cannabis a new lease on life in the United States.  In 1992, four years before Proposition 215, the Endocannabinoid System was discovered by Raphael Mechoulam, PhD, a professor of medicinal chemistry and natural products at Hebrew University in Jerusalem, Israel.  Since then, scientists have found out that the Endocannabinoid System is responsible for maintaining many of our normal bodily functions.  This array of discoveries can extend from helping maintain healthy bone density and naturally preventing diabetes.  This is where AGRiMED Industries, LLC will pick up the research and develop over fifty strains of medical cannabis directed towards intervention in an array of multiple diseases. 

PUM: In the face of the opioid epidemic, you feel you will offer patients alternatives, tell us more about the various medicines you will provide?

Dr. Mitchell: The opioid dependency epidemic is a result of physicians overprescribing the dangerous habit-forming and potentially deadly opioid medications.  It is reported that 79% of all opioid overdose related deaths start with an in-office physician’s prescription.  Physician education of the Endocannabinoid System will be the first line of defense in combating the opioid dependent epidemic.  Secondarily, understanding the medicinal usage and pain control elements of the cannabinoid plant must be studied and understood.  These two above concepts are not understood by the modern day physician because he/she were not taught this system in medical school. 

An immediate application for cannabis use against the opioid dependent epidemic would be the authorized approval of cannabis for: 


•           Risk reduction of accidental death in opioid medication usage can be reduced with cannabis thereby reducing the need for increased opioid medication.


•           Authorization of cannabis certificates for withdrawal of symptomatology in opioid dependent addiction. 


AGRiMED Industries, LLC will use scientific knowledge in cultivating the best strains of cannabis with varying ratios of THC to CBDs.  Much of this science has already been done.  In the near future, AGRiMED will make it available to The Keystone State which was the vision of Governor Wolf when he signed the Medical Cannabis Act of April 2016. 

  AGRiMED Industries, LLC will give me a major projection platform where I can help many people in the Commonwealth of Pennsylvania beyond my normal private practice. 



Other PUM Stories
Vibrant Pittsburgh and Urban Affairs Foundation Offer Mini Grants to Strengthen Civic Engagement among the Region’s Diverse Community-Based Organizations
Vibrant Pittsburgh and Urban Affairs Foundation Offer Mini Grants...

Read More »

Neighborhood Allies Outlines it's Priority Geographies
Neighborhood Allies Priority Geographies Neighborhood Allies is a...

Read More »

ACLU-PA Files Suit to Block State’s “Silencing Act”
ACLU-PA Files Suit to Block State’s “Silencing Act”...

Read More »

Turnovers kill bid for 7th title -PACKERS 31, STEELERS 25
  Turnovers kill bid for 7th title - PACKERS 31, STEELERS 25...

Read More »


Pittsburgh Urban Media